Clinical Trials Directory

Trials / Completed

CompletedNCT03279835

Evaluation of a Short Version Computerized Test for Processing Speed to Detect Cognitive Disorders in HIV+ Patients

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The objective of this prospective study is to evaluate the prevalence of neurocognitive impairments in HIV infected patients comparing patients with and without HAART. Recent studies have demonstrated a specific HIV infected patients neurocognitive disorders profile. These cognitive disorders concern primarily information processing speed, memory recall, attentional abilities, work related memory, executive functions, and psychometrical speed. This cognitive profile is similar to another highly documented one, described for another central nervous system disease (CNS): multiple sclerosis. In both CNS diseases, the earliest and most severe disorder is the one related to the information processing speed. For the multiple sclerosis patients, a short cognitive test (SDMT) is actually used not only to identify cognitive disorders presence, but also in order to predict a long term disability worsening. A digital version of this test (CSCT), has recently been developed in order to make this early evaluation easier. We hypothesize that CSCT alteration would also predict HAND, in HIV infected patients. A complete neuropsychological assessment is highly time and personal consuming. This short (approximatively 2 minutes) digital test would be highly helpful to identify patients, who will need a more extensive neuropsychological assessment.

Conditions

Interventions

TypeNameDescription
OTHERClassic evaluation of neurocognitive functionsSymbol Digit Modalities Test (SDMT)
OTHERNew evaluation of neurocognitive functionsCognitive Speed Computerized Test (CSCT)

Timeline

Start date
2017-03-16
Primary completion
2018-10-30
Completion
2018-10-30
First posted
2017-09-12
Last updated
2019-05-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03279835. Inclusion in this directory is not an endorsement.